Estrogen and Alzheimer's disease: The apolipoprotein connection

Endocrinology

Volumn 145, Issue 7, 2004, Pages 3062-3064

  MacLusky, Neil J ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ESTRADIOL; ESTROGEN;

ALZHEIMER DISEASE; ATHEROSCLEROSIS; BRAIN CORTEX; BRAIN REGION; COGNITION; DEGENERATIVE DISEASE; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; NERVE CELL; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; POSTMENOPAUSE; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; SHORT SURVEY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; APOLIPOPROTEINS; BRAIN; ESTROGENS; HUMANS;

EID: 3042541852     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0427     Document Type: Short Survey

References (31)

1. Nathan BP, Barsukova AG, Shen F, McAsey M, Struble RG 2004 Estrogen facilitates neurite extension via apolipoprotein E in cultured adult mouse cortical neurons. Endocrinology 145:3065-3073
2. Toran-Allerand CD 1976 Sex steroids and the development of the newborn mouse hypothalamus and preoptic area in vitro: Implication for sexual differentiation. Brain Res 189:413-427
3. Woolley CS, McEwen BS 1992 Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci 12:2549-2554
4. Hao J, Janssen WG, Tang Y, Roberts JA, McKay H, Lasley B, Allen PB, Greengard P, Rapp PR, Kordower JH, Hof PR, Morrison JH 2003 Estrogen increases the number of spinophilin-immunoreactive spines in the hippocampus of young and aged female rhesus monkeys. J Comp Neurol 465:540-550
5. Green PS, Simpkins JW 2000 Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci 18:347-358
6. Jaffe AB, Toran-Allerand CD, Greengard P, Gandy SE 1994 Estrogen regulates metabolism of Alzheimer amyloid β precursor protein. J Biol Chem 269:13065-13068
7. Luine VN 1985 Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 89:484-490
8. Leranth C, Roth RH, Elsworth JD, Naftolin F, Horvath TL, Redmond Jr DE 2000 Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory. J Neurosci 20:8604-8609
9. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN 3rd, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J; WHIMS Investigators 2003 Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2651-2662
10. Beral V 2003 Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419-427
11. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD 2002 Postmenopausal hormone replacement therapy: scientific review. JAMA 288:872-881
12. Lehtimaki T, Dastidar P, Jokela H, Koivula T, Lehtinen S, Ehnholm C, Punnonen R 2002 Effect of long-term hormone replacement therapy on atherosclerosis progression in postmenopausal women relates to functional apolipoprotein E genotype. J Clin Endocrinol Metab 87:4147-4153
13. Fazekas F, Strasser-Fuchs S, Kollegger H, Berger T, Kristoferitsch W, Schmidt H, Enzinger C, Schiefermeier M, Schwarz C, Kornek B, Reindl M, Huber K, Grass R, Wimmer G, Vass K, Pfeiffer KH, Hartung HP, Schmidt R 2001 Apolipoprotein E ∈4 is associated with rapid progression of multiple sclerosis. Neurology 57:853-857
14. Tang G, Xie H, Xu L, Hao Y, Lin D, Ren D 2002 Genetic study of apolipoprotein E gene, α-1 antichymotrypsin gene in sporadic Parkinson disease. Am J Med Genet 114:446-449
15. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA 1993 Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923
16. Yaffe K, Haan M, Byers A, Tangen C, Kuller L 2000 Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology 54:1949-1954
17. Struble RG, Rosario ER, Kircher ML, Ludwig SM, McAdamis PJ, Watabe K, McAsey ME, Cady C, Nathan BP 2003 Regionally specific modulation of brain apolipoprotein E in the mouse during the estrous cycle and by exogenous 17β estradiol. Exp Neurol 183:638-644
18. Srivastava RA, Krul ES, Lin RC, Schonfeld G 1997 Regulation of lipoprotein metabolism by estrogen in inbred strains of mice occurs primarily by posttranscriptional mechanisms. Mol Cell Biochem 173:161-168
19. Nathan BP, Jiang Y, Wong GK, Shen F, Brewer GJ, Struble RG 2002 Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein. Brain Res 928:96-105
20. Horsburgh K, Macrae IM, Carswell H 2002 Estrogen is neuroprotective via an apolipoprotein E-dependent mechanism in a mouse model of global ischemia. J Cereb Blood Flow Metab 22:1189-1195
21. Stone DJ, Rozovsky I, Morgan TE, Anderson CP, Finch CE 1998 Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer's disease. J Neurosci 18:3180-3185
22. Toran-Allerand CD, Guan X, MacLusky NJ, Horvath TL, Diano S, Singh M, Connolly Jr ES, Nethrapalli IS, Tinnikov AA 2002 ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J Neurosci 22:8391-8401
23. Sandstrom NJ, Williams CL 2004 Spatial memory retention is enhanced by acute and continuous estradiol replacement. Horm Behav 45:128-135
24. Nilsen J, Brinton RD 2002 Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology 143:205-212
25. Moffat SD, Zonderman AB, Metter EJ, Kawas C, Blackman MR, Harman SM, Resnick SM 2004 Free testosterone and risk for Alzheimer disease in older men. Neurology 62:188-193
26. Sunderland T, Merril CR, Harrington MG, Lawlor BA, Molchan SE, Martinez R, Murphy DL 1989 Reduced plasma dehydroepiandrosterone concentrations in Alzheimer's disease. Lancet 2:570
27. Leranth C, Hajszan T, MacLusky NJ 2004 Androgens increase spine synapse density in the CA1 hippocampal subfield of ovariectomized female rats. J Neurosci 24:495-499
28. Bastianetto S, Ramassamy C, Poirier J, Quirion R 1999 Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res 66:35-41
29. Hogervorst E, Lehmann DJ, Warden DR, McBroom J, Smith AD 2002 Apolipoprotein E ∈4 and testosterone interact in the risk of Alzheimer's disease in men. Int J Geriatr Psychiatry 17:938-940
30. Levin-Allerhand J, McEwen BS, Lominska CE, Lubahn DB, Korach KS, Smith JD 2001 Brain region-specific up-regulation of mouse apolipoprotein E by pharmacological estrogen treatments. J Neurochem 79:796-803
31. Rozovsky I, Hoving S, Anderson CP, O'Callaghan J, Finch CE 2002 Equine estrogens induce apolipoprotein E and glial fibrillary acidic protein in mixed glial cultures. Neurosci Lett 323:191-194